Cornovus Pharmaceuticals
Farmington, US · Founded 2011 · Delaware corporation
Founders & leadership
GM
Glenn MattesExecutive
RM
Robert Mark Van AllenExecutive
Board
RN
Raymond NeagBoard director
TS
Timothy ShannonBoard director
BL
Bruce LiangBoard director
DW
Daniel WagnerBoard director
Reported raises · per SEC filings
Form D private placements$3.1M disclosed across 3 rounds · 2014–2024
▶$500KraisedJan 2024 · 1 investors · OtherRule 506(c)
▶$500KraisedJan 2024 · 1 investors · Other
Rule 506(c)Officers, directors & promoters on the filing
- R. Mark Van AllenExecutive Officer
- Offering amount
- $2M
- Amount sold
- $500K
- Minimum investment
- $1
- First sale
- Jan 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$982.6KraisedAug 2016 · 2 investors · PharmaceuticalsRule 506(b)
▶$982.6KraisedAug 2016 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Glenn MattesExecutive Officer, Director
- Bruce LiangDirector
- Raymond NeagDirector
- Timothy ShannonDirector
- Daniel WagnerDirector
- Offering amount
- $2.3M
- Amount sold
- $982.6K
- Minimum investment
- $1
- First sale
- Aug 2016
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
▶$1.6MraisedMar 2014 · 1 investors · OtherRule 506(b)
▶$1.6MraisedMar 2014 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Robert Mark Van AllenExecutive Officer
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- Minimum investment
- $1.6M
- First sale
- Feb 2014
- Incorporated
- Corporation, Delaware, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Cornovus Pharmaceuticals raised?
- Cornovus Pharmaceuticals has disclosed $3.1M raised across 3 rounds.
- Where is Cornovus Pharmaceuticals headquartered?
- Cornovus Pharmaceuticals is headquartered in Farmington, US.